BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1263731)

  • 1. Complications of treatment with clofazimine (Lamprene: B663).
    Jopling WH
    Lepr Rev; 1976 Mar; 47(1):1-3. PubMed ID: 1263731
    [No Abstract]   [Full Text] [Related]  

  • 2. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofazimine (lamprene or B663) in lepra reactions.
    Imkamp FM
    Lepr Rev; 1981 Jun; 52(2):135-40. PubMed ID: 7242222
    [No Abstract]   [Full Text] [Related]  

  • 6. A long term trial with clofazimine in reactive lepromatous leprosy.
    Plock H; Leiker DL
    Lepr Rev; 1976 Mar; 47(1):25-34. PubMed ID: 1263732
    [No Abstract]   [Full Text] [Related]  

  • 7. Lamprene (clofazimine) and its side effects.
    Salafia A; Kharkar RD
    Indian J Lepr; 1987; 59(3):313-4. PubMed ID: 3440850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamprene (clofazimine) in leprosy. Basic information.
    Yawalkar SJ; Vischer W
    Lepr Rev; 1979 Jun; 50(2):135-44. PubMed ID: 396428
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofazimine in pregnancy complicated by leprosy.
    Farb H; West DP; Pedvis-Leftick A
    Obstet Gynecol; 1982 Jan; 59(1):122-3. PubMed ID: 7078842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of clofazimine (Lamprene) in the management of reactive phases of leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):105-9. PubMed ID: 1100948
    [No Abstract]   [Full Text] [Related]  

  • 11. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection.
    Garrelts JC
    DICP; 1991 May; 25(5):525-31. PubMed ID: 2068838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).
    McDougall AC; Jones RL
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):116-20. PubMed ID: 6260900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofazimine-induced enteropathy in a patient of leprosy.
    Singh H; Azad K; Kaur K
    Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978.
    Browne SG; Harman DJ; Waudby H; McDougall AC
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clofazimine: detailed studies of small intestine functions.
    Bhasin DK; Kumar B; Broor SL; Kaur S; Malik AM; Mehra SK
    Indian J Lepr; 1985; 57(2):364-72. PubMed ID: 4078364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-intestinal side effects of clofazimine.
    Lal S; Garg BR; Hameedulla A
    Lepr India; 1981 Apr; 53(2):285-8. PubMed ID: 7253579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of clofazimine in leprosy patients.
    Feng PC; Fenselau CC; Jacobson RR
    Drug Metab Dispos; 1981; 9(6):521-4. PubMed ID: 6120809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy.
    Hogerzeil LM
    Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lamprène. New therapeutic indications (excluding leprosy)].
    Beurey J; Weber M; Chaulieu Y
    LARC Med; 1982 Jan; 2(1):48-50, 53, 55. PubMed ID: 6219260
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin A levels of ichthyotic and non-ichthyotic skin and plasma of leprosy patients with and without clofazimine therapy.
    Bharadwaj VP; Sritharan V; Venkatesan K; Girdhar A; Ramu G
    Indian J Med Res; 1982 Jun; 75():773-7. PubMed ID: 7129548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.